Scribe Therapeutics (NASDAQ:SCTX) Major Shareholder Bio Fund Ii L.P. Ah Purchases 333,333 Shares

Scribe Therapeutics Inc. (NASDAQ:SCTX) major shareholder Bio Fund Ii L.P. Ah purchased 333,333 shares of Scribe Therapeutics stock in a transaction that occurred on Monday, July 27th. The shares were bought at an average price of $15.00 per share, with a total value of $4,999,995.00. Following the transaction, the insider owned 2,385,075 shares in the company, valued at approximately $35,776,125. The trade was a 16.25% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Scribe Therapeutics Stock Up 1.7%

Shares of Scribe Therapeutics stock opened at $18.36 on Thursday. Scribe Therapeutics Inc. has a twelve month low of $17.31 and a twelve month high of $25.49.